Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Return on Sales [ROS] (2017 - 2023)

Updated

Summit Therapeutics' Return on Sales [ROS] came in at -268266.82% for Q2 2023, down 262865.97 percentage points from -5400.85% a year earlier and down 139237.15 percentage points from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Return on Sales [ROS] (2017 - 2023) Analysis & Trends

For FY2022, Summit Therapeutics' Return on Sales [ROS] was -10225.39%, down 5461.10 percentage points from FY2021.

  • Return on Sales [ROS] carries a five-year change of -7964.89 percentage points (FY2017 to FY2022).
  • Going back by year, Return on Sales [ROS] was -4764.29% in FY2021 (+1420.94 pp), -6185.23% in FY2020 (+5227.26 pp), -11412.49% in FY2019 and -122.87% in FY2018.
  • The Q2 2023 figure represents the lowest quarterly Return on Sales [ROS] in data going back to Q1 2019.
  • Year-over-year, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -43646.26 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2022 (a gain of 36230.73 percentage points), and the weakest in Q2 2023 (a drop of 262865.97 percentage points).
  • Business Quant data shows SMMT's Return on Sales [ROS] at -129029.67% (Q1 2023), -10225.39% (Q4 2022) and -7700.00% (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Summit Therapeutics 12.28 Bn 10.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -268,266.82%
Mar 31, 2023 -129,029.67%
Dec 31, 2022 -10,225.39%
Sep 30, 2022 -7,700.00%
Jun 30, 2022 -5,400.85%
Mar 31, 2022 -8,863.20%
Dec 31, 2021 -10,377.29%
Sep 30, 2021 -1,488.62%
Jun 30, 2021 -41,631.58%
Mar 31, 2021 -8,814.06%
Dec 31, 2020 -6,246.49%
Sep 30, 2020 -9,359.67%
Jun 30, 2020 -9,032.94%
Mar 31, 2020 -6,409.72%
Dec 31, 2019 -18,820.24%
Oct 31, 2019 -15,553.23%
Sep 30, 2019 -4,182.43%
Jul 31, 2019 -13,157.94%
Mar 31, 2019 -4,578.93%
Oct 31, 2018 -3,288.59%
API Access

Summit Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SMMT&period=max&api_key=YOUR_API_KEY